Assessing risks and mechanisms of idiosyncratic drug toxicity by fingerprints of cell signaling responses

Author:

Medvedev Alexander V.ORCID,Makarov Sergei,Medvedeva Lyubov A.,Martsen Elena,Gorman Kristen L.,Lin Benjamin,Makarov Sergei S.

Abstract

ABSTRACTIdiosyncratic drug-induced liver injury (DILI) is the leading cause of post-marketing drug withdrawal. Here, we describe a straightforward DILI liability assessment approach based on fingerprinting cell signaling responses. The readout is the activity of transcription factors (TF) that link signaling pathways to genes. Using a multiplex reporter assay for 45 TFs in hepatocytic cells, we assessed TF activity profiles (TFAP) for 13 pharmacological classes. The TFAP signatures were consistent with primary drug activity but transformed into different, ‘off-target’ signatures at certain concentrations (COFF). We show that the off-target signatures pertained to DILI-relevant mechanisms, including mitochondria malfunction, proteotoxicity, and lipid peroxidation. Based on reported plasma concentrations in humans (CMAX), drugs do not reach the off-target thresholds in vivo, consistent with the lack of overt toxicity in the population. However, DILI liability drugs were dangerously close to the off-target thresholds. We characterized this closeness by the COFF/CMAXratio termed the ‘safety margin’ (SM). Most-DILI-concern drugs invariably showed smaller safety margins than their less-concern counterparts in each pharmacological class and across classes (median SM values of 6.4 and 212.7, respectively (P<0.00015)). Therefore, the TFAP approach helps to explain idiosyncratic drug toxicity and provides clear quantitative metrics for its probability and the underlying mechanisms.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3